5 ETF Picks For October

 | Oct 04, 2017 02:50AM ET

The month of October will be highlighted by a deluge of earnings and investors’ quest for clarity on the Fed’s likely policy tightening as well as passage of tax reforms. As per the Earnings Trends issued on Sep 27, 2017, earnings growth of the S&P 500 in Q3 is expected to be 3.2% on 5% higher revenues. Third-quarter revenue growth is projected to be way higher than 2.2% in Q3 of 2016 while earnings growth might come in slightly lower than what we saw (4%) in the year-ago cycle.

The economic front looks upbeat as evident by the 13-year high manufacturing activity recorded in September and a jump in new auto sales. The broader market has also seen a decent start in October, though many fear disturbingly low levels of volatility and chances of a crash if Trump fails to push through the tax reform.

Against this backdrop, it is important to pin point ETFs that could safeguard investors from any sudden market swing as well as play the current momentum.

Loncar Cancer Immunotherapy ETF CNCR

This can be a great momentum play. Biotech ETFs especially those with a focus on cancer therapy are on fire lately on a slew of mergers and acquisitions, FDA’s approval of CAR-T cell therapy and improving research and developments.

Shares of Endocyte Inc. (NASDAQ:ECYT) soared 34 drugs so far in 2017 including three in September. This is already way higher than 22 approvals seen last year.

First Trust Mid Cap Growth AlphaDEX Fund FNY

With both the United States and global economy on the rise, it is time to play mid-cap growth ETFs like FNY. This is because the greenback may gain strength in the coming days on an improving U.S. economy. This will go against large-cap stocks with greater foreign exposure. But through md-cap growth ETFs, investors can mitigate the adverse impact of a rising dollar while tap the surge in the global economy alongside.

iShares Dow Jones Transportation Average Index Fund IYT

As per the source, Dow Jones Transportation index enjoys a : 5 Sector ETFs for Revenue Growth Play ).

If this was not enough, airline stocks surged on Oct 3 following Cowen & Co. analyst Helane Becker’s reiteration of an outperform rating on Delta Airlines (NYSE:DAL). The analyst sees Delta’s Top and Flop Sector ETFs of Q3 ).

iShares Edge MSCI Multifactor Global ETF ACWF

A look at global ETFs is also warranted given the upbeat prospects. This way, investors can mitigate certain risks. And the fund looks to track the global developed and emerging market large- and mid-cap stocks chosen on the basis of value, quality, momentum and low-size scores (read: Global Dividend Payments Upbeat in Q2: ETFs to Benefit ).

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Barron's 400 ETF BFOR

This ETF seeks to track the performance of the rules-based and fundamentals-driven Barron’s 400 Index. The benchmark looks to select high performing U.S. stocks based on four fundamental factors — growth, valuation, profitability and cash flow. The fund will suit investors seeking quality exposure (read: Are We Nearing a Bear Market? ETFs to Lean On ).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes